Bastani Peivand, Ghanbarzadegan Arash, Vatankhah Soudabeh, Samadbeik Mahnaz
Health Human Resources Research Center, Department of Health Service Management, School of Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Health Service Management, School of Management and Medical Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Health Serv Insights. 2019 Apr 10;12:1178632919837629. doi: 10.1177/1178632919837629. eCollection 2019.
Pharmaceutical strategic purchasing is considered as a key to improve access to medicines especially for developing countries. The aim of this scoping review is to determine the most important components affecting pharmaceutical strategic purchasing. Here, we employed a comprehensive search strategy across PubMed, ProQuest, EBSCO, ISI Web of Science, Scopus, ScienceDirect, and Google Scholar for the terms related to medicines strategic purchasing. Among 13 included studies, 7 (53.85%) and 6 (46.15%) studies belonged to the developing and developed countries, respectively. Six main variables were emphasized as the effective variables on medicines strategic purchasing, including purchasing interventions, target group and service users, providers and suppliers of interventions, methods and motivations, price, and finally structure and organization. It seems that the insurance organizations of developing countries can achieve strategic purchasing only through the modification of the pharmaceutical pricing system and payment systems. Furthermore, they should pay attention to the real needs of target groups (demand) and modify the structure and organization as well as purchasing the most effective medicines from the best pharmaceutical providers.
药品战略采购被视为改善药品可及性的关键，尤其是对发展中国家而言。本综述的目的是确定影响药品战略采购的最重要因素。在此，我们在PubMed、ProQuest、EBSCO、ISI Web of Science、Scopus、ScienceDirect和谷歌学术上采用了全面的检索策略，以查找与药品战略采购相关的术语。在纳入的13项研究中，分别有7项（53.85%）和6项（46.15%）研究来自发展中国家和发达国家。强调了六个主要变量作为药品战略采购的有效变量，包括采购干预措施、目标群体和服务使用者、干预措施的提供者和供应商、方法和动机、价格，以及最后的结构和组织。发展中国家的保险机构似乎只有通过修改药品定价系统和支付系统才能实现战略采购。此外，它们应关注目标群体的实际需求（需求），修改结构和组织，并从最佳药品供应商处采购最有效的药品。
